at://
/
app.bsky.feed.post
/
3mnsfmuhfrs2r
sign in
All
4
Record
2
Post
1
PostEmbed
1
Post
by @danabra.mov
PostEmbed
by @danabra.mov
Record
by @jimpick.com
Record
by @atsui.org
+ new component
Post
4/8 Dapagliflozin reduced HHF by 82% in CMP variant carriers (vs. 30% in non-carriers). Treatment brought the absolute rate of HHF down to 3.1%, effectively neutralizing the excess genetic risk and mirroring the rate seen in non-carriers.
2d
Shino Kany
